Ernst Geutjes | Partner

Ernst Geutjes

Contact me

030 2296090

Ernst has over 10 years of experience in cancer research, oncology drug development and venturing. Ernst holds a PhD in molecular cancer genetics from the Netherlands Cancer Institute (NKI-AvL) after which he continued his career as business developer at the research- and technology organization TNO, where he had a role in spinning-of biotech companies. With Aglaia he is responsible for the analysis of investment proposals, scouting of new investment opportunities and offers strategic and operational support to Aglaia’s portfolio companies. He is acting managing director at Sapreme Technologies and board observer with Macrophage Pharma.


Home > Team > Ernst Geutjes

© 2021 Aglaia Oncology Funds | Privacy | Sitemap
Aglaia Oncology Funds